India's Dr Reddy's signs licensing pact to sell Immutep's cancer drug
08/12/2025 07:31
Dec 8 (Reuters) - Indian drugmaker Dr Reddy's REDY.NS signed an exclusive licensing pact with Australia's Immutep IMM.AX to manufacture, develop and distribute the latter's cancer therapy, the companies said on Monday. The deal, worth up to nearly $350 million, will allow Dr Reddy's to distribute eftilagimod alfa, Immutep's cancer therapy, in all regions barring North America, Europe, Japan and Greater China. (Reporting by Nandan Mandayam in Bengaluru; Editing by Sonia Cheema) ((Nandan.Mandayam@thomsonreuters.com; Mobile: +91 9591011727;))